Newsfeeds - Spark Newswire

2 minute read

M&A
News

Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers $2.5M Milestone Payment to XOMA

Today, 3:59 PM

Kuros Biosciences AG ("Kuros" or the "Company"), a leader in next generation bone graft technologies, notes the completion of the acquisition of Checkmate Pharmaceuticals (NASDAQ: CMPI) by Regeneron Pharmaceuticals (NASDAQ: REGN).

CMPI

4 minute read

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

By Shanthi Rexaline

Today, 3:59 PM

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering rate hike fears.

ABBV

4 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:59 PM

Gainers

ACC

3 minute read

Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge

By Lisa Levin

Today, 3:59 PM

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

CMPI

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 3:59 PM

AFIB

3 minute read

Mid-Day Market Update: Crude Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher

By Lisa Levin

Today, 3:59 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

CMPI

3 minute read

38 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 3:59 PM

Gainers

ACC

2 minute read

Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points

By Lisa Levin

Today, 3:59 PM

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 400 points on Tuesday.

ACC

1 minute read

Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal

By Vandana Singh

Today, 3:59 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will acquire Checkmate Pharmaceuticals Inc (NASDAQ:CMPI) for $10.50 per share, equivalent to a total equity value of approximately…

CMPI

1 minute read

BTIG Maintains Buy on Checkmate Pharmaceuticals, Lowers Price Target to $9

By Benzinga Newsdesk

Today, 3:59 PM

BTIG analyst Kaveri Pohlman maintains Checkmate Pharmaceuticals (NASDAQ:CMPI) with a Buy and lowers the price target from $29 to $9.

CMPI